Catalyst Funds Management Pty Ltd reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 65.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,920 shares of the company’s stock after selling 3,680 shares during the quarter. Catalyst Funds Management Pty Ltd’s holdings in HCA Healthcare were worth $896,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in the stock. Capital World Investors boosted its holdings in shares of HCA Healthcare by 3.8% during the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after purchasing an additional 179,443 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of HCA Healthcare by 1.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after purchasing an additional 36,414 shares during the period. Viking Global Investors LP boosted its holdings in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Legal & General Group Plc lifted its stake in HCA Healthcare by 0.8% in the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock valued at $479,267,000 after acquiring an additional 8,478 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in HCA Healthcare by 1.1% in the third quarter. Invesco Ltd. now owns 1,100,929 shares of the company’s stock valued at $469,216,000 after acquiring an additional 11,829 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on HCA. Royal Bank Of Canada reduced their target price on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Truist Financial reduced their target price on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Robert W. Baird reduced their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Jefferies Financial Group reissued a “buy” rating and issued a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Oppenheimer dropped their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $515.77.
HCA Healthcare Stock Up 0.5%
NYSE:HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company’s 50 day moving average is $465.16 and its 200-day moving average is $483.61. The firm has a market cap of $87.49 billion, a price-to-earnings ratio of 13.56, a P/E/G ratio of 1.25 and a beta of 1.18.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the firm posted $6.45 EPS. The company’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
